Learn about the key changes to the In Vitro Diagnostic Directive and the areas you should be actively considering.
mHealth Software Regulation: part II: Regulations for mHealth in the USA, the largest diagnostic market.
mHealth Software Regulation: part I: European regulation surrounding the rapid growing mHealth market.
Octylphenol ethoxylates are now included in the Annex XIV of REACH. What does it mean for LFIAs that use OPEs?
Seralite®– FLC Serum granted registration by the Brazilian Health Regulatory Agency (ANVISA) Abingdon Health is pleased to announce Seralite® – FLC Serum has...
A peer-reviewed scientific publication featuring detailed clinical validation of Seralite®-FLC has been published in the British Journal of Haematology and is now available...
Abingdon Health announces GMP compliant facilities and registration with U.S. FDA Scope of Quality Management System extended Abingdon Health announces the registration of...
Abingdon Health announces FDA registration and CE marking of new lateral flow immunoassay Reader – ADxLR5® Abingdon Health is pleased to announce the...
